The Efficacy and Safety of Utidelone Plus Tislelizumab and Bevacizumab for Advanced or Metastatic Triple-negative Breast Cancer (UTILIZABLE)

Avastin (bevacizumab) - Roche

utidelone IV (UTD1) - Beijing Biostar Technologies

Tevimbra (tislelizumab-jsgr) - BeOne Medicines

Chen Gong; Tengfei Chao; Huihua Xiong

Jul 17, 2026